Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial
- Submitting institution
-
The University of Sheffield
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 68
- Type
- D - Journal article
- DOI
-
10.1001/jamaoncol.2015.5570
- Title of journal
- JAMA Oncology
- Article number
- -
- First page
- 493
- Volume
- 2
- Issue
- 4
- ISSN
- 2374-2437
- Open access status
- Out of scope for open access requirements
- Month of publication
- January
- Year of publication
- 2016
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
21
- Research group(s)
-
B - Cancer
- Citation count
- 41
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- (a) The author made a substantial contribution to carrying out the study; and to analysis and interpretation of study data. (b) The author helped critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
